Forbes Women’s Summit: Pfizer Shares ‘The Way Forward’ to Driving Social Impact

Jun 20, 2018 9:00 AM ET
Blog

In today’s increasingly complex world, businesses – and the visionary leaders behind them – are playing an important role in catalyzing the new, innovative and inclusive approaches needed to solve pressing global challenges and create more equitable, just and healthy communities.

That was the theme yesterday at the 2018 Forbes Women’s Summit in New York City, where Caroline Roan, Vice President of Corporate Responsibility at Pfizer and President of the Pfizer Foundation*, joined other luminaries to showcase the impact of women who are driving transformative change. Speaking as part of a panel titled, “The Visionaries: Leading With Purpose,” Caroline shared insights from Pfizer’s global health programs to increase access to medicines.

"As a global pharmaceutical company, and also as stewards of improving global health, we recognize at Pfizer the importance of working together with governments, civil society and other stakeholders to ensure that underserved communities around the world are able to access the medicines we develop," Roan said. “With that in mind, we are constantly evolving our programs and co-creating new, creative partnerships that increase access to healthcare, while supporting progress toward achieving the vision of the United Nations Sustainable Development Goals for a better world.”

Pfizer’s global health priorities focus on reducing barriers to quality healthcare for women around the world—particularly those women living in resource-poor and difficult-to-reach communities. In fact, the Pfizer Foundation recently announced a new $5 million grant commitment to integrate health services for women and children in low- and middle-income countries.

To learn about Pfizer’s innovative work to improve global health, visit https://www.pfizer.com/responsibility/individual-voices.

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.